TY - JOUR
T1 - Dyslipidemia and the vulnerable plaque
AU - Farmer, John A.
AU - Gotto, Antonio
PY - 2002/1/1
Y1 - 2002/1/1
N2 - In the last decade, an increasingly sophisticated understanding of the pathogenesis of atherosclerosis and its cardiovascular consequences has emerged. The characteristics of the unstable atherosclerotic plaque, the substrate for the majority of acute coronary events, have been well defined: mild-to-moderate stenosis, a lipid-rich pool, few smooth muscle cells, a friable fibrous cap, and macrophage infiltration. Lipid modification, an important cardiovascular risk reduction strategy, induces a number of effects at the vascular level that may contribute to the clinical benefits seen in large-scale, prospective prevention trials. New developments in imaging technologies may afford improved opportunities to visualize the atrisk plaque and may provide new insights into the optimal management of the unstable plaque.
AB - In the last decade, an increasingly sophisticated understanding of the pathogenesis of atherosclerosis and its cardiovascular consequences has emerged. The characteristics of the unstable atherosclerotic plaque, the substrate for the majority of acute coronary events, have been well defined: mild-to-moderate stenosis, a lipid-rich pool, few smooth muscle cells, a friable fibrous cap, and macrophage infiltration. Lipid modification, an important cardiovascular risk reduction strategy, induces a number of effects at the vascular level that may contribute to the clinical benefits seen in large-scale, prospective prevention trials. New developments in imaging technologies may afford improved opportunities to visualize the atrisk plaque and may provide new insights into the optimal management of the unstable plaque.
UR - http://www.scopus.com/inward/record.url?scp=0036089356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036089356&partnerID=8YFLogxK
U2 - 10.1053/pcad.2002.123474
DO - 10.1053/pcad.2002.123474
M3 - Article
C2 - 12077715
AN - SCOPUS:0036089356
SN - 0033-0620
VL - 44
SP - 415
EP - 428
JO - Progress in Cardiovascular Diseases
JF - Progress in Cardiovascular Diseases
IS - 6
ER -